Valuation Telix Pharmaceuticals Limited Nasdaq

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-29 EDT			5-day change	1st Jan Change
9.510 ^USD	+2.70%		-0.31%	+26.97%

10-21	Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the Third Quarter Ended September 30, 2026	CI
10-21	Telix Pharmaceuticals Limited Reaffirms Earnings Guidance for the Fiscal Year 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,209	2,300	3,263	8,238	3,794	4,580	-	-
Change	-	4.1%	41.89%	152.44%	-53.95%	20.73%	-	-
Enterprise Value (EV) ¹	2,187	2,187	3,149	8,098	4,167	5,109	5,070	5,052
Change	-	-0.02%	44.01%	157.15%	-48.55%	22.62%	-0.76%	-0.35%
P/E	-27.2x	-21.7x	626x	170x	-375x	203x	2,399x	56.5x
PBR	1,024x	28.7x	21.9x	14.5x	6.43x	4.91x	6.46x	5.9x
PEG	-	-1.2x	-6x	0x	3x	-1x	-26.2x	0x
Capitalization / Revenue	291x	14.4x	6.49x	10.5x	3.17x	3.29x	2.91x	2.48x
EV / Revenue	288x	13.7x	6.27x	10.3x	3.48x	3.67x	3.22x	2.73x
EV / EBITDA	-31.2x	-32.3x	53.9x	81.6x	74.4x	58x	62.8x	30.2x
EV / EBIT	-29.1x	-29.9x	60.9x	88.7x	98.7x	92.1x	110x	39.2x
EV / FCF	-35.2x	-29.9x	223x	282x	-68.4x	239x	-991x	58.6x
FCF Yield	-2.84%	-3.35%	0.45%	0.35%	-1.46%	0.42%	-0.1%	1.71%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.285	-0.335	0.0161	0.1446	-0.0299	0.0666	0.00562	0.2384
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7.596	160.1	502.5	783.2	1,198	1,391	1,573	1,849
EBITDA ¹	-70.07	-67.8	58.44	99.28	55.98	88.01	80.73	167.4
EBIT ¹	-75.25	-73.18	51.69	91.26	42.23	55.46	46	128.7
Net income ¹	-80.51	-104.1	5.211	49.92	-10.1	27.02	2.507	81.51
Net Debt ¹	-22.02	-113	-114.1	-139.5	372.9	528.7	489.7	471.8
Reference price ²	7.75	7.27	10.08	24.61	11.20	13.48	13.48	13.48
Nbr of stocks (in thousands)	285,073	316,343	323,727	334,724	338,721	339,784	-	-
Announcement Date	2/23/22	2/27/23	2/22/24	2/20/25	2/19/26	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	16.92x	6.39x	12.26x	1.77%	64.14B
ARGENX SE	30.57x	8.11x	26.59x	0.05%	55.53B
LONZA GROUP AG	36.68x	6.52x	19.45x	0.88%	53.03B
IQVIA HOLDINGS INC.	35.39x	3.41x	14.74x	-.--%	45.99B
BEONE MEDICINES AG	49.25x	5.68x	31.09x	-.--%	42.45B
REVOLUTION MEDICINES, INC.	-19.59x	189.6x	-20.86x	-.--%	40.45B
CELLTRION, INC.	31.7x	8.06x	20.96x	0.41%	32.25B
GENMAB A/S	47.12x	8.37x	28.08x	-.--%	34.47B
WUXI BIOLOGICS (CAYMAN) INC.	27.96x	5.9x	15.29x	-.--%	24.23B
Average	28.44x	26.89x	16.40x	0.34%	43.62B
Weighted average by Cap.	27.96x	25.38x	16.46x	0.45%